WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug. 10, 2006--NanoViricides, Inc. (Pink Sheets:NNVC) announced today that the Company’s latest drug, RabiCide(TM)-I, an anti-rabies drug, is now scheduled to begin preclinical animal testing in Vietnam by early 2007. Although not an important disease in the United States, rabies kills over 50,000 people per year in the subtropical regions of Asia, India and Africa. This drug was developed at the request of the National Institute of Hygiene and Epidemiology of the Ministry of Health, Government of Vietnam.
